Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. SYNLAB AG
  6. Summary
    SYAB   DE000A2TSL71

SYNLAB AG

(SYAB)
  Report
Real-time Estimate Cboe Europe  -  03:17 2022-06-29 am EDT
17.17 EUR   -1.07%
06/21SYNLAB : Gets a Neutral rating from JP Morgan
MD
06/21SYNLAB Seeks M&A
CI
06/21TRANSCRIPT : SYNLAB AG - Analyst/Investor Day
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
06/23/2022 06/24/2022 06/27/2022 06/28/2022 06/29/2022 Date
16.69(c) 16.81(c) 17(c) 17.35(c) 17.21 Last
0 100 100 650 0 Volume
-0.89% +0.72% +1.13% +2.06% -0.81% Change
More quotes
Estimated financial data (e)
Sales 2022 3 173 M 3 340 M 3 340 M
Net income 2022 315 M 332 M 332 M
Net Debt 2022 1 502 M 1 581 M 1 581 M
P/E ratio 2022 11,8x
Yield 2022 1,75%
Sales 2023 2 917 M 3 071 M 3 071 M
Net income 2023 222 M 234 M 234 M
Net Debt 2023 1 387 M 1 460 M 1 460 M
P/E ratio 2023 17,3x
Yield 2023 1,46%
Capitalization 3 856 M 4 058 M 4 058 M
EV / Sales 2022 1,69x
EV / Sales 2023 1,80x
Nbr of Employees 25 750
Free-Float 75,7%
More Financials
Company
Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis. 
Read more
More about the company
Ratings of SYNLAB AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SYNLAB AG
06/21SYNLAB : Gets a Neutral rating from JP Morgan
MD
06/21SYNLAB Seeks M&A
CI
06/21TRANSCRIPT : SYNLAB AG - Analyst/Investor Day
CI
06/08SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/31SYNLAB : Barclays maintains a Buy rating
MD
05/25SYNLAB : JP Morgan remains Neutral
MD
05/13SYNLAB : Receives a Buy rating from Deutsche Bank
MD
05/13SYNLAB : JP Morgan sticks Neutral
MD
05/12SYNLAB : Barclays reiterates its Buy rating
MD
05/12TRANSCRIPT : SYNLAB AG, Q1 2022 Earnings Call, May 12, 2022
CI
05/12SYNLAB : Gets a Neutral rating from JP Morgan
MD
05/12SYNLAB : Jefferies reaffirms its Buy rating
MD
05/12SYNLAB reports a strong start to the fiscal year 2022
EQ
05/12SYNLAB AG Revises Earnings Guidance for 2022
CI
05/12SYNLAB AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
More news
News in other languages on SYNLAB AG
06/21SYNLAB cherche une fusion-acquisition
05/31OPINIONES DE LOS ANALISTAS DEL DÍA : Acerinox, Kering, Volkswagen, Amundi, Siemens Gamesa,..
05/31BOLSA DE MADRID : Europa (casi) renuncia al petróleo ruso
05/12Laborspezialist Synlab erhöht Umsatzziel für 2022
05/12SYNLAB mit starkem Auftakt in das Geschäftsjahr 2022
More news
Analyst Recommendations on SYNLAB AG
More recommendations
Chart SYNLAB AG
Duration : Period :
SYNLAB AG Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 17,35 €
Average target price 22,49 €
Spread / Average Target 29,6%
EPS Revisions
Managers and Directors
Mathieu Olivier Floreani Chairman-Management Board & CEO
Sami Badarani Chief Financial Officer
David Raymond Ebsworth Chairman-Supervisory Board
Santiago Valor Garcia Chief Medical Officer
Henrik Andreasen Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNLAB AG-25.85%4 058
SONIC HEALTHCARE LIMITED-29.08%10 927
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-28.09%5 372
DR. LAL PATHLABS LIMITED-43.16%2 145
DIAGNOSTICOS DA AMÉRICA S.A.-51.45%1 756
FULGENT GENETICS, INC.-45.48%1 722